Work

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Year: 2011

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v118.21.4152.4152

Authors: Wei Ding, Tait D. Shanafelt, Kari Rabe, Timothy G. Call, Clive S. Zent, Neil Kay, David James Inwards, Deborah Bowen, Mark R. Litzow, Susan L Slager, Susan Schwager, William J Hogan

Institution: Mayo Clinic

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556674582

FWCI: 0.29

Cites:

Cited by: 2

Related to: 10